1. Home
  2. VRT vs SNY Comparison

VRT vs SNY Comparison

Compare VRT & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertiv Holdings LLC

VRT

Vertiv Holdings LLC

HOLD

Current Price

$300.23

Market Cap

103.6B

Sector

Technology

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.04

Market Cap

113.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRT
SNY
Founded
N/A
1994
Country
United States
France
Employees
N/A
74846
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.6B
113.9B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VRT
SNY
Price
$300.23
$46.04
Analyst Decision
Buy
Buy
Analyst Count
20
5
Target Price
$269.44
$58.00
AVG Volume (30 Days)
5.0M
2.6M
Earning Date
04-22-2026
04-23-2026
Dividend Yield
0.08%
3.48%
EPS Growth
166.41
N/A
EPS
0.99
N/A
Revenue
N/A
N/A
Revenue This Year
$34.04
$3.49
Revenue Next Year
$23.82
$6.10
P/E Ratio
$325.90
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$80.51
$43.32
52 Week High
$330.30
$55.73

Technical Indicators

Market Signals
Indicator
VRT
SNY
Relative Strength Index (RSI) 54.47 43.66
Support Level $233.21 $45.20
Resistance Level N/A $48.79
Average True Range (ATR) 13.33 0.75
MACD 0.19 -0.21
Stochastic Oscillator 38.54 6.59

Price Performance

Historical Comparison
VRT
SNY

About VRT Vertiv Holdings LLC

Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: